Tzogani, K., Florez, B., Markey, G., Caleno, M., Olimpieri, O. M., Melchiorri, D., . . . Pignatti, F. (2019). European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. ESMO Open.
Chicago-стиль цитированияTzogani, Kyriaki, et al. "European Medicines Agency Review of Ixazomib (Ninlaro) for the Treatment of Adult Patients With Multiple Myeloma Who Have Received At Least One Prior Therapy." ESMO Open 2019.
MLA-цитированиеTzogani, Kyriaki, et al. "European Medicines Agency Review of Ixazomib (Ninlaro) for the Treatment of Adult Patients With Multiple Myeloma Who Have Received At Least One Prior Therapy." ESMO Open 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.